Loading...

Marta Marthas

Title(s)Professor, SCHOOL OF VETERINARY MEDICINE
SchoolUniversity of California, Davis
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Passive-Active Immunization Strategies Against Pediatric AIDS
    NIH/NIAID R01AI062518Mar 1, 2006 - Feb 28, 2010
    Role: Principal Investigator
    Passive-Active Vaccine Strategies Against Pediatric AIDS
    NIH/NIAID R21AI062518Sep 30, 2004 - Feb 28, 2006
    Role: Principal Investigator
    Vaccine to Prevent HIV Infection in Pregnancy &Newborns
    NIH/NIAID R21AI052000Sep 1, 2002 - Aug 31, 2005
    Role: Principal Investigator
    VACCINE APPROACHES TO PREVENT HIV/AIDS IN CHILDREN
    NIH/NIAID R01AI046320Sep 1, 1999 - Jun 30, 2005
    Role: Principal Investigator
    ORAL TRANSMISSION AND VIRAL VARIANTS IN PEDIATRICS AIDS
    NIH/NIAID R01AI039109Sep 30, 1995 - Aug 31, 2001
    Role: Principal Investigator
    13TH ANNUAL SYMPOSIUM ON AIDS ANIMAL MODELS
    NIH/NCRR R13RR011039Aug 1, 1995 - Jul 31, 1996
    Role: Principal Investigator
    VACCINATION AGAINST INFECTION WITH CELL-ASSOCIATED SIV
    NIH/NIAID R01AI031383Sep 30, 1991 - Jul 31, 1996
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Marthas ML, Van Rompay KK, Abbott Z, Earl P, Buonocore-Buzzelli L, Moss B, Rose NF, Rose JK, Kozlowski PA, Abel K. Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques. Vaccine. 2011 Apr 12; 29(17):3124-37. PMID: 21377510.
      View in: PubMed
    2. von Gegerfelt A, Valentin A, Alicea C, Van Rompay KK, Marthas ML, Montefiori DC, Pavlakis GN, Felber BK. Emergence of simian immunodeficiency virus-specific cytotoxic CD4+ T cells and increased humoral responses correlate with control of rebounding viremia in CD8-depleted macaques infected with Rev-independent live-attenuated simian immunodeficiency virus. J Immunol. 2010 Sep 15; 185(6):3348-58. PMID: 20702730.
      View in: PubMed
    3. Van Rompay KK, Abel K, Earl P, Kozlowski PA, Easlick J, Moore J, Buonocore-Buzzelli L, Schmidt KA, Wilson RL, Simon I, Moss B, Rose N, Rose J, Marthas ML. Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV. Vaccine. 2010 Feb 10; 28(6):1481-92. PMID: 19995539.
      View in: PubMed
    4. Morgan C, Marthas M, Miller C, Duerr A, Cheng-Mayer C, Desrosiers R, Flores J, Haigwood N, Hu SL, Johnson RP, Lifson J, Montefiori D, Moore J, Robert-Guroff M, Robinson H, Self S, Corey L. The use of nonhuman primate models in HIV vaccine development. PLoS Med. 2008 Aug 12; 5(8):e173. PMID: 18700814.
      View in: PubMed
    5. Van Rompay KK, Durand-Gasselin L, Brignolo LL, Ray AS, Abel K, Cihlar T, Spinner A, Jerome C, Moore J, Kearney BP, Marthas ML, Reiser H, Bischofberger N. Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects. Antimicrob Agents Chemother. 2008 Sep; 52(9):3144-60. PMID: 18573931.
      View in: PubMed
    6. Marthas ML, Miller CJ. Developing a neonatal HIV vaccine: insights from macaque models of pediatric HIV/AIDS. Curr Opin HIV AIDS. 2007 Sep; 2(5):367-74. PMID: 19372914.
      View in: PubMed
    7. Van Rompay KK, Johnson JA, Blackwood EJ, Singh RP, Lipscomb J, Matthews TB, Marthas ML, Pedersen NC, Bischofberger N, Heneine W, North TW. Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection. Retrovirology. 2007 Apr 06; 4:25. PMID: 17417971; PMCID: PMC1852805.
    8. Florese RH, Van Rompay KK, Aldrich K, Forthal DN, Landucci G, Mahalanabis M, Haigwood N, Venzon D, Kalyanaraman VS, Marthas ML, Robert-Guroff M. Evaluation of passively transferred, nonneutralizing antibody-dependent cellular cytotoxicity-mediating IgG in protection of neonatal rhesus macaques against oral SIVmac251 challenge. J Immunol. 2006 Sep 15; 177(6):4028-36. PMID: 16951366.
      View in: PubMed
    9. Forthal DN, Landucci G, Cole KS, Marthas M, Becerra JC, Van Rompay K. Rhesus macaque polyclonal and monoclonal antibodies inhibit simian immunodeficiency virus in the presence of human or autologous rhesus effector cells. J Virol. 2006 Sep; 80(18):9217-25. PMID: 16940533.
      View in: PubMed
    10. Van Rompay KK, Kearney BP, Sexton JJ, Colón R, Lawson JR, Blackwood EJ, Lee WA, Bischofberger N, Marthas ML. Evaluation of oral tenofovir disoproxil fumarate and topical tenofovir GS-7340 to protect infant macaques against repeated oral challenges with virulent simian immunodeficiency virus. J Acquir Immune Defic Syndr. 2006 Sep; 43(1):6-14. PMID: 16810108.
      View in: PubMed
    11. Van Rompay KK, Singh RP, Heneine W, Johnson JA, Montefiori DC, Bischofberger N, Marthas ML. Structured treatment interruptions with tenofovir monotherapy for simian immunodeficiency virus-infected newborn macaques. J Virol. 2006 Jul; 80(13):6399-410. PMID: 16775328.
      View in: PubMed
    12. Abel K, Pahar B, Van Rompay KK, Fritts L, Sin C, Schmidt K, Colón R, McChesney M, Marthas ML. Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses. J Virol. 2006 Jul; 80(13):6357-67. PMID: 16775324.
      View in: PubMed
    13. von Gegerfelt AS, Alicea C, Valentin A, Morrow M, van Rompay KK, Ayash-Rashkovsky M, Markham P, Else JG, Marthas ML, Pavlakis GN, Ruprecht RM, Felber BK. Long lasting control and lack of pathogenicity of the attenuated Rev-independent SIV in rhesus macaques. AIDS Res Hum Retroviruses. 2006 Jun; 22(6):516-28. PMID: 16796527.
      View in: PubMed
    14. Van Rompay KK, Blackwood EJ, Landucci G, Forthal D, Marthas ML. Role of CD8+ cells in controlling replication of nonpathogenic Simian Immunodeficiency Virus SIVmac1A11. Virol J. 2006 Apr 03; 3:22. PMID: 16584561.
      View in: PubMed
    15. Greenier JL, Van Rompay KK, Montefiori D, Earl P, Moss B, Marthas ML. Simian immunodeficiency virus (SIV) envelope quasispecies transmission and evolution in infant rhesus macaques after oral challenge with uncloned SIVmac251: increased diversity is associated with neutralizing antibodies and improved survival in previously immunized animals. Virol J. 2005 Feb 14; 2:11. PMID: 15710048; PMCID: PMC552328.
    16. Van Rompay KK, Abel K, Lawson JR, Singh RP, Schmidt KA, Evans T, Earl P, Harvey D, Franchini G, Tartaglia J, Montefiori D, Hattangadi S, Moss B, Marthas ML. Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV. J Acquir Immune Defic Syndr. 2005 Feb 01; 38(2):124-34. PMID: 15671796.
      View in: PubMed
    17. Milush JM, Kosub D, Marthas M, Schmidt K, Scott F, Wozniakowski A, Brown C, Westmoreland S, Sodora DL. Rapid dissemination of SIV following oral inoculation. AIDS. 2004 Dec 03; 18(18):2371-80. PMID: 15622313.
      View in: PubMed
    18. Van Rompay KK, Marthas ML, Bischofberger N. Tenofovir primes rhesus macaque cells in vitro for enhanced interleukin-12 secretion. Antiviral Res. 2004 Aug; 63(2):133-8. PMID: 15302142.
      View in: PubMed
    19. Van Rompay KK, Singh RP, Brignolo LL, Lawson JR, Schmidt KA, Pahar B, Canfield DR, Tarara RP, Sodora DL, Bischofberger N, Marthas ML. The clinical benefits of tenofovir for simian immunodeficiency virus-infected macaques are larger than predicted by its effects on standard viral and immunologic parameters. J Acquir Immune Defic Syndr. 2004 Aug 01; 36(4):900-14. PMID: 15220696.
      View in: PubMed
    20. Belshe R, Franchini G, Girard MP, Gotch F, Kaleebu P, Marthas ML, McChesney MB, McCullough R, Mhalu F, Salmon-Ceron D, Sekaly RP, van Rompay K, Verrier B, Wahren B, Weissenbacher M. Support for the RV144 HIV vaccine trial. Science. 2004 Jul 09; 305(5681):177-80; author reply 177-80. PMID: 15247455.
      View in: PubMed
    21. Support for the RV144 HIV vaccine trial. Science. 2004 Jul 09; 305(5681):177-80; author reply 177-80. PMID: 15250069.
      View in: PubMed
    22. Van Rompay KK, Brignolo LL, Meyer DJ, Jerome C, Tarara R, Spinner A, Hamilton M, Hirst LL, Bennett DR, Canfield DR, Dearman TG, Von Morgenland W, Allen PC, Valverde C, Castillo AB, Martin RB, Samii VF, Bendele R, Desjardins J, Marthas ML, Pedersen NC, Bischofberger N. Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques. Antimicrob Agents Chemother. 2004 May; 48(5):1469-87. PMID: 15105094; PMCID: PMC400569.
    23. Van Rompay KK, Singh RP, Pahar B, Sodora DL, Wingfield C, Lawson JR, Marthas ML, Bischofberger N. CD8+-cell-mediated suppression of virulent simian immunodeficiency virus during tenofovir treatment. J Virol. 2004 May; 78(10):5324-37. PMID: 15113912; PMCID: PMC400346.
    24. Safrit JT, Ruprecht R, Ferrantelli F, Xu W, Kitabwalla M, Van Rompay K, Marthas M, Haigwood N, Mascola JR, Luzuriaga K, Jones SA, Mathieson BJ, Newell ML. Immunoprophylaxis to prevent mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr. 2004 Feb 01; 35(2):169-77. PMID: 14722451.
      View in: PubMed
    25. Vogel TU, Reynolds MR, Fuller DH, Vielhuber K, Shipley T, Fuller JT, Kunstman KJ, Sutter G, Marthas ML, Erfle V, Wolinsky SM, Wang C, Allison DB, Rud EW, Wilson N, Montefiori D, Altman JD, Watkins DI. Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239. J Virol. 2003 Dec; 77(24):13348-60. PMID: 14645590; PMCID: PMC296068.
    26. Van Rompay KK, Greenier JL, Cole KS, Earl P, Moss B, Steckbeck JD, Pahar B, Rourke T, Montelaro RC, Canfield DR, Tarara RP, Miller C, McChesney MB, Marthas ML. Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251. J Virol. 2003 Jan; 77(1):179-90. PMID: 12477823; PMCID: PMC140621.
    27. Makori N, Tarantal AF, Lü FX, Rourke T, Marthas ML, McChesney MB, Hendrickx AG, Miller CJ. Functional and morphological development of lymphoid tissues and immune regulatory and effector function in rhesus monkeys: cytokine-secreting cells, immunoglobulin-secreting cells, and CD5(+) B-1 cells appear early in fetal development. Clin Diagn Lab Immunol. 2003 Jan; 10(1):140-53. PMID: 12522052; PMCID: PMC145291.
    28. Van Rompay KK, Schmidt KA, Lawson JR, Singh R, Bischofberger N, Marthas ML. Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus. J Infect Dis. 2002 Nov 15; 186(10):1508-13. PMID: 12404171.
      View in: PubMed
    29. Sodora DL, Milush JM, Ware F, Wozniakowski A, Montgomery L, McClure HM, Lackner AA, Marthas M, Hirsch V, Johnson RP, Douek DC, Koup RA. Decreased levels of recent thymic emigrants in peripheral blood of simian immunodeficiency virus-infected macaques correlate with alterations within the thymus. J Virol. 2002 Oct; 76(19):9981-90. PMID: 12208974; PMCID: PMC136511.
    30. Abel K, Alegria-Hartman MJ, Rothaeusler K, Marthas M, Miller CJ. The relationship between simian immunodeficiency virus RNA levels and the mRNA levels of alpha/beta interferons (IFN-alpha/beta) and IFN-alpha/beta-inducible Mx in lymphoid tissues of rhesus macaques during acute and chronic infection. J Virol. 2002 Aug; 76(16):8433-45. PMID: 12134046; PMCID: PMC155165.
    31. von Gegerfelt AS, Liska V, Li PL, McClure HM, Horie K, Nappi F, Montefiori DC, Pavlakis GN, Marthas ML, Ruprecht RM, Felber BK. Rev-independent simian immunodeficiency virus strains are nonpathogenic in neonatal macaques. J Virol. 2002 Jan; 76(1):96-104. PMID: 11739675; PMCID: PMC135725.
    32. Abel K, Alegria-Hartman MJ, Zanotto K, McChesney MB, Marthas ML, Miller CJ. Anatomic site and immune function correlate with relative cytokine mRNA expression levels in lymphoid tissues of normal rhesus macaques. Cytokine. 2001 Dec 07; 16(5):191-204. PMID: 11814315.
      View in: PubMed
    33. Marthas ML, Lu D, Penedo MC, Hendrickx AG, Miller CJ. Titration of an SIVmac251 stock by vaginal inoculation of Indian and Chinese origin rhesus macaques: transmission efficiency, viral loads, and antibody responses. AIDS Res Hum Retroviruses. 2001 Oct 10; 17(15):1455-66. PMID: 11679158.
      View in: PubMed
    34. Van Rompay KK, McChesney MB, Aguirre NL, Schmidt KA, Bischofberger N, Marthas ML. Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection. J Infect Dis. 2001 Aug 15; 184(4):429-38. PMID: 11471100.
      View in: PubMed
    35. Greenier JL, Miller CJ, Lu D, Dailey PJ, Lü FX, Kunstman KJ, Wolinsky SM, Marthas ML. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques. J Virol. 2001 Apr; 75(8):3753-65. PMID: 11264364.
      View in: PubMed
    36. Van Rompay KK, Miller MD, Marthas ML, Margot NA, Dailey PJ, Canfield DR, Tarara RP, Cherrington JM, Aguirre NL, Bischofberger N, Pedersen NC. Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA. J Virol. 2000 Feb; 74(4):1767-74. PMID: 10644348.
      View in: PubMed
    37. Osterhaus AD, Pedersen N, van Amerongen G, Frankenhuis MT, Marthas M, Reay E, Rose TM, Pamungkas J, Bosch ML. Isolation and partial characterization of a lentivirus from talapoin monkeys (Myopithecus talapoin). Virology. 1999 Jul 20; 260(1):116-24. PMID: 10405363.
      View in: PubMed
    38. Tarantal AF, Marthas ML, Shaw JP, Cundy K, Bischofberger N. Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): safety and efficacy studies. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 01; 20(4):323-33. PMID: 10096575.
      View in: PubMed
    39. van Rompay KK, Dailey PJ, Tarara RP, Canfield DR, Aguirre NL, Cherrington JM, Lamy PD, Bischofberger N, Pedersen NC, Marthas ML. Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn Rhesus macaques. J Virol. 1999 Apr; 73(4):2947-55. PMID: 10074144.
      View in: PubMed
    40. Van Rompay KK, Cherrington JM, Marthas ML, Lamy PD, Dailey PJ, Canfield DR, Tarara RP, Bischofberger N, Pedersen NC. 9-[2-(Phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPA. Antimicrob Agents Chemother. 1999 Apr; 43(4):802-12. PMID: 10103184.
      View in: PubMed
    41. Luciw PA, Shaw KE, Shacklett BL, Marthas ML. Importance of the intracytoplasmic domain of the simian immunodeficiency virus (SIV) envelope glycoprotein for pathogenesis. Virology. 1998 Dec 05; 252(1):9-16. PMID: 9875311.
      View in: PubMed
    42. Van Rompay KK, Berardi CJ, Aguirre NL, Bischofberger N, Lietman PS, Pedersen NC, Marthas ML. Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection. AIDS. 1998 Jun 18; 12(9):F79-83. PMID: 9662190.
      View in: PubMed
    43. Van Rompay KK, Marthas ML, Lifson JD, Berardi CJ, Vasquez GM, Agatep E, Dehqanzada ZA, Cundy KC, Bischofberger N, Pedersen NC. Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques. AIDS Res Hum Retroviruses. 1998 Jun 10; 14(9):761-73. PMID: 9643376.
      View in: PubMed
    44. Van Rompay KK, Berardi CJ, Dillard-Telm S, Tarara RP, Canfield DR, Valverde CR, Montefiori DC, Cole KS, Montelaro RC, Miller CJ, Marthas ML. Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. J Infect Dis. 1998 May; 177(5):1247-59. PMID: 9593009.
      View in: PubMed
    45. Miller CJ, Marthas M, Greenier J, Lu D, Dailey PJ, Lu Y. In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques. J Virol. 1998 Apr; 72(4):3248-58. PMID: 9525652.
      View in: PubMed
    46. Van Rompay KK, Marthas ML. Antiretroviral drug trials. Science. 1997 Jun 06; 276(5318):1482-4. PMID: 9190679.
      View in: PubMed
    47. Breckenridge A, Kitchen V, Darbyshire JH. Antiretroviral drug trials. Science. 1997 Jun 06; 276(5318):1481-2; author reply 1443-4. PMID: 9190678.
      View in: PubMed
    48. Van Rompay KK, Greenier JL, Marthas ML, Otsyula MG, Tarara RP, Miller CJ, Pedersen NC. A zidovudine-resistant simian immunodeficiency virus mutant with a Q151M mutation in reverse transcriptase causes AIDS in newborn macaques. Antimicrob Agents Chemother. 1997 Feb; 41(2):278-83. PMID: 9021180.
      View in: PubMed
    49. Van Rompay KK, Cherrington JM, Marthas ML, Berardi CJ, Mulato AS, Spinner A, Tarara RP, Canfield DR, Telm S, Bischofberger N, Pedersen NC. 9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaques. Antimicrob Agents Chemother. 1996 Nov; 40(11):2586-91. PMID: 8913470.
      View in: PubMed
    50. Lane JH, Tarantal AF, Pauley D, Marthas M, Miller CJ, Lackner AA. Localization of simian immunodeficiency virus nucleic acid and antigen in brains of fetal macaques inoculated in utero. Am J Pathol. 1996 Oct; 149(4):1097-104. PMID: 8863658.
      View in: PubMed
    51. Otsyula MG, Miller CJ, Tarantal AF, Marthas ML, Greene TP, Collins JR, van Rompay KK, McChesney MB. Fetal or neonatal infection with attenuated simian immunodeficiency virus results in protective immunity against oral challenge with pathogenic SIVmac251. Virology. 1996 Aug 01; 222(1):275-8. PMID: 8806509.
      View in: PubMed
    52. Van Rompay KK, Otsyula MG, Tarara RP, Canfield DR, Berardi CJ, McChesney MB, Marthas ML. Vaccination of pregnant macaques protects newborns against mucosal simian immunodeficiency virus infection. J Infect Dis. 1996 Jun; 173(6):1327-35. PMID: 8648204.
      View in: PubMed
    53. Otsyula MG, Miller CJ, Marthas ML, Van Rompay KK, Collins JR, Pedersen NC, McChesney MB. Virus-induced immunosuppression is linked to rapidly fatal disease in infant rhesus macaques infected with simian immunodeficiency virus. Pediatr Res. 1996 Apr; 39(4 Pt 1):630-5. PMID: 8848337.
      View in: PubMed
    54. Gardner MB, Luciw PA, Sawai ET, Marthas ML, Miller CJ, McChesney MB, Lerche NW, Pedersen NC. Simian retrovirus vaccines: simian retrovirus and simian immunodeficiency lentivirus. AIDS Res Hum Retroviruses. 1996 Mar 20; 12(5):399-401. PMID: 8882318.
      View in: PubMed
    55. Van Rompay KK, Spinner A, Otsyula M, McChesney MB, Marthas ML. Attenuated retrovirus vaccines and AIDS. Science. 1995 Nov 17; 270(5239):1218-9; author reply 1220-2. PMID: 7502051.
      View in: PubMed
    56. Tarantal AF, Marthas ML, Gargosky SE, Otysula M, McChesney MB, Miller CJ, Hendrickx AG. Effects of viral virulence on intrauterine growth in SIV-infected fetal rhesus macaques (Macaca mulatta). J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 01; 10(2):129-38. PMID: 7552476.
      View in: PubMed
    57. Marthas ML, van Rompay KK, Otsyula M, Miller CJ, Canfield DR, Pedersen NC, McChesney MB. Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques. J Virol. 1995 Jul; 69(7):4198-205. PMID: 7769679.
      View in: PubMed
    58. Van Rompay K, Marthas ML. "The Duesberg phenomenon": what does it mean? Science. 1995 Jan 13; 267(5195):157. PMID: 7809614.
      View in: PubMed
    59. Van Rompay KK, Otsyula MG, Marthas ML, Miller CJ, McChesney MB, Pedersen NC. Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS. Antimicrob Agents Chemother. 1995 Jan; 39(1):125-31. PMID: 7695293.
      View in: PubMed
    60. Lohman BL, McChesney MB, Miller CJ, McGowan E, Joye SM, Van Rompay KK, Reay E, Antipa L, Pedersen NC, Marthas ML. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J Virol. 1994 Nov; 68(11):7021-9. PMID: 7933084.
      View in: PubMed
    61. Miller CJ, Marthas M, Torten J, Alexander NJ, Moore JP, Doncel GF, Hendrickx AG. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J Virol. 1994 Oct; 68(10):6391-400. PMID: 8083977.
      View in: PubMed
    62. Lackner AA, Vogel P, Ramos RA, Kluge JD, Marthas M. Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus. Am J Pathol. 1994 Aug; 145(2):428-39. PMID: 8053500.
      View in: PubMed
    63. van Rompay KK, Marthas ML, Pedersen NC. Prophylactic ZDV dosing frequency in macaques. J Acquir Immune Defic Syndr. 1994 Jun; 7(6):627-9. PMID: 8192813.
      View in: PubMed
    64. Lohman BL, McChesney MB, Miller CJ, Otsyula M, Berardi CJ, Marthas ML. Mucosal immunization with a live, virulence-attenuated simian immunodeficiency virus (SIV) vaccine elicits antiviral cytotoxic T lymphocytes and antibodies in rhesus macaques. J Med Primatol. 1994 Feb-May; 23(2-3):95-101. PMID: 7966240.
      View in: PubMed
    65. Ahmad S, Lohman B, Marthas M, Giavedoni L, el-Amad Z, Haigwood NL, Scandella CJ, Gardner MB, Luciw PA, Yilma T. Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Res Hum Retroviruses. 1994 Feb; 10(2):195-204. PMID: 8198872.
      View in: PubMed
    66. Kang DW, Ohkawa S, Difabio S, Merrill KW, Fujihashi K, Yamamoto M, Miller CJ, Marthas M, McGhee JR, Eldridge JH. Characterization of T and B cells isolated from mucosa-associated tissues of the rhesus macaque. Cell Immunol. 1993 Oct 15; 151(2):379-91. PMID: 8402944.
      View in: PubMed
    67. Marthas ML, Ramos RA, Lohman BL, Van Rompay KK, Unger RE, Miller CJ, Banapour B, Pedersen NC, Luciw PA. Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac. J Virol. 1993 Oct; 67(10):6047-55. PMID: 8371353.
      View in: PubMed
    68. Mandell CP, Jain NC, Miller CJ, Marthas M, Dandekar S. Early hematologic changes in rhesus macaques (Macaca mulatta) infected with pathogenic and nonpathogenic isolates of SIVmac. J Med Primatol. 1993 Feb-May; 22(2-3):177-86. PMID: 8105092.
      View in: PubMed
    69. Giavedoni LD, Planelles V, Haigwood NL, Ahmad S, Kluge JD, Marthas ML, Gardner MB, Luciw PA, Yilma TD. Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection. J Virol. 1993 Jan; 67(1):577-83. PMID: 8416384.
      View in: PubMed
    70. Van Rompay KK, Marthas ML, Ramos RA, Mandell CP, McGowan EK, Joye SM, Pedersen NC. Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3'-azido-3'-deoxythymidine prevents SIV infection. Antimicrob Agents Chemother. 1992 Nov; 36(11):2381-6. PMID: 1489181.
      View in: PubMed
    71. Unger RE, Marthas ML, Pratt-Lowe E, Padrid PA, Luciw PA. The nef gene of simian immunodeficiency virus SIVmac1A11. J Virol. 1992 Sep; 66(9):5432-42. PMID: 1501282.
      View in: PubMed
    72. Gardner M, Yamamoto J, Marthas M, Miller C, Jennings M, Rosenthal A, Luciw P, Planelles V, Yilma T, Giavedoni L. SIV and FIV vaccine studies at UC Davis: 1991 update. AIDS Res Hum Retroviruses. 1992 Aug; 8(8):1495-8. PMID: 1334682.
      View in: PubMed
    73. McGhee JR, Yamamoto M, Kang DW, Eldridge JH, Mestecky J, Moldoveanu Z, Compans R, Kiyono H, Miller C, Marthas M. Isotype of anti-SIV responses in infected rhesus macaques and in animals immunized by mucosal routes. AIDS Res Hum Retroviruses. 1992 Aug; 8(8):1389. PMID: 1466963.
      View in: PubMed
    74. Miller CJ, Kang DW, Marthas M, Moldoveanu Z, Kiyono H, Marx P, Eldridge JH, Mestecky J, McGhee JR. Genital secretory immune response to chronic simian immunodeficiency virus (SIV) infection: a comparison between intravenously and genitally inoculated rhesus macaques. Clin Exp Immunol. 1992 Jun; 88(3):520-6. PMID: 1606737.
      View in: PubMed
    75. Luciw PA, Shaw KE, Unger RE, Planelles V, Stout MW, Lackner JE, Pratt-Lowe E, Leung NJ, Banapour B, Marthas ML. Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac). AIDS Res Hum Retroviruses. 1992 Mar; 8(3):395-402. PMID: 1571198.
      View in: PubMed
    76. Marthas ML, Miller CJ, Sutjipto S, Higgins J, Torten J, Lohman BL, Unger RE, Ramos RA, Kiyono H, McGhee JR. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV. J Med Primatol. 1992 Feb-May; 21(2-3):99-107. PMID: 1433273.
      View in: PubMed
    77. Unger RE, Marthas ML, Lackner AA, Pratt-Lowe E, Lohman BL, Van Rompay K, Luciw PA. Detection of simian immunodeficiency virus DNA in macrophages from infected rhesus macaques. J Med Primatol. 1992 Feb-May; 21(2-3):74-81. PMID: 1433270.
      View in: PubMed
    78. Planelles V, Haigwood NL, Marthas ML, Mann KA, Scandella C, Lidster WD, Shuster JR, Van Kuyk R, Marx PA, Gardner MB. Functional and immunological characterization of SIV envelope glycoprotein produced in genetically engineered mammalian cells. AIDS Res Hum Retroviruses. 1991 Nov; 7(11):889-98. PMID: 1760229.
      View in: PubMed
    79. Banapour B, Marthas ML, Ramos RA, Lohman BL, Unger RE, Gardner MB, Pedersen NC, Luciw PA. Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac. J Virol. 1991 Nov; 65(11):5798-805. PMID: 1920617.
      View in: PubMed
    80. Lohman BL, Higgins J, Marthas ML, Marx PA, Pedersen NC. Development of simian immunodeficiency virus isolation, titration, and neutralization assays which use whole blood from rhesus monkeys and an antigen capture enzyme-linked immunosorbent assay. J Clin Microbiol. 1991 Oct; 29(10):2187-92. PMID: 1939569.
      View in: PubMed
    81. Banapour B, Marthas ML, Munn RJ, Luciw PA. In vitro macrophage tropism of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac). Virology. 1991 Jul; 183(1):12-9. PMID: 1711254.
      View in: PubMed
    82. Marthas ML, Sutjipto S, Higgins J, Lohman B, Torten J, Luciw PA, Marx PA, Pedersen NC. Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J Virol. 1990 Aug; 64(8):3694-700. PMID: 2164591.
      View in: PubMed
    83. Kestler H, Kodama T, Ringler D, Marthas M, Pedersen N, Lackner A, Regier D, Sehgal P, Daniel M, King N. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science. 1990 Jun 01; 248(4959):1109-12. PMID: 2160735.
      View in: PubMed
    84. Barry PA, Pratt-Lowe E, Unger RE, Marthas M, Alcendor DJ, Luciw PA. Molecular interactions of cytomegalovirus and the human and simian immunodeficiency viruses. J Med Primatol. 1990; 19(3-4):327-37. PMID: 2172542.
      View in: PubMed
    85. Marthas ML, Banapour B, Sutjipto S, Siegel ME, Marx PA, Gardner MB, Pedersen NC, Luciw PA. Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus. J Med Primatol. 1989; 18(3-4):311-9. PMID: 2547965.
      View in: PubMed
    86. Temin RG, Marthas M. Factors Influencing the Effect of Segregation Distortion in Natural Populations of DROSOPHILA MELANOGASTER. Genetics. 1984 Jul; 107(3):375-93. PMID: 17246219.
      View in: PubMed